Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

- Kneebone, Andrew, Fraser-Browne, Carol, Duchesne, Gillian M., Fisher, Richard, Frydenberg, Mark, Herschtal, Alan, Williams, Scott G., Brown, Chris, Delprado, Waeick, Haworth, Annette, Joseph, David J., Martin, Jarad M., Matthews, John H. L., Millar, Jeremy L., Sidhom, Milllar, Spry, Nigel, Tang, Colin I., Turner, Sandra, Wiltshire, Kirsty L., Woo, Henry H., Davis, Ian D., Lim, Tee S., Pearse, Maria

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

- Duchesne, Gillian M., Woo, Henry H., Millar, Jeremy, Milne, Roger, Smith, Rosemary G., Spry, Nigel, Stockler, Martin, Syme, Rodney A., Tai, Keen Hun, Turner, Sandra, Bassett, Julie K., Bowe, Steven J., D'Este, Catherine, Frydenberg, Mark, King, Madeleine, Ledwich, Leo, Loblaw, Andrew, Malone, Shawn

Researching depression in prostate cancer patients: factors, timing, and measures

- Sharpley, Christopher F., Bitsika, Vicki, Christie, David R. H., Denham, James W., Duchesne, Gillian M., Couper, Jeremy W.

Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants

- Haworth, Annette, Ebert, Martin A., St. Clair, Shaun, Carey, Brendan M., Flynn, Anthony, Bottomley, David M., Duchesne, Gillian M., Joseph, David, Ash, Daniel